Dr. Tolba on the Use of Afatinib in NRG1-Mutated Lung Adenocarcinoma

preview_player
Показать описание
Khaled A. Tolba, MD, MBBCh, discusses the use of afatinib in NRG1 fusion–positive lung adenocarcinoma.

Рекомендации по теме